Related Tags >> Pfizer FDA heart disease cox 2 inhibitor

Celebrex News

Most Popular Celebrex Story

Pfizer, Adolor ink pain drug deal

December 5, 2007 — 6:59am ET

Continuing on its deal-making quest, Pfizer has signed an agreement with Exton, PA-based Adolor for ADL5859 and ADL5747. The two pain drugs Read more...

Celebrex Press Releases

Pfizer is Market Leader in the Global Pain Treatment Market: companiesandmarkets.com

Latest Headlines

Doc sentenced to prison for faking research data
June 28, 2010
ALSO NOTED: Medicines Company gets not approvable letter; Sun, Taro merger called off; and much more...
May 28, 2008
Pfizer, Adolor ink pain drug deal
December 5, 2007
FDA panel backs Celebrex for children
November 29, 2006
Press Release: Pfizer to realign U.S. sales organization
November 28, 2006
ALSO NOTED: Neurogen licenses Wyeth drug; Pliva gets generic approval; and much more...
November 27, 2006
Pfizer prepares red carpet for market analysts
November 26, 2006
ALSO NOTED: Coley touts Phase I data; Covance expands to China, Singapore; and much more...
April 30, 2006
Celebrex works against precancerous polyps
April 3, 2006
SPOTLIGHT: Celebrex linked to heart attack risk
February 28, 2006
Fresh danger signs for Cox-2 inhibitors
November 13, 2005
FDA hands Pfizer a non-approvable letter for injectable Cox-2
September 19, 2005
Metric: Drug tab for seniors surges 25% in four years
September 15, 2005
ALSO NOTED: Meda buys German drug group; SEC asks Pfizer for Cox-2 data; Alabama providing breaks for new research center; and
August 9, 2005
Regulators add warning to Bextra, allow new indication
August 1, 2005
FEATURE: New generation of biomarkers may reduce health risks
July 21, 2005

Paid Research Reports

More Research Reports >>